Catechol-O-methyltransferase polymorphisms and schizophrenia: A transmission disequilibrium study in multiply affected families

Psychiatric Genetics

Volumn 7, Issue 3, 1997, Pages 97-101

  Kunugi, H ^a,d   Vallada, H P ^a   Sham, P C ^a   Hoda, F ^a   Arranz, M J ^a   Li, T ^a   Nanko, S ^d   Murray, R M ^a   McGuffin, P ^b   Owen, M ^b   Gill, M ^c   Collier, D A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c ST JAMES S HOSPITAL   (Ireland)

^d TEIKYO UNIVERSITY   (Japan)

Author keywords

Biochemical; Catecholamine; Chromosome 22; Dopamine; Genetics; Linkage; Psychosis; VCFS

Indexed keywords

ADRENALIN; CATECHOL METHYLTRANSFERASE; CATECHOLAMINE; DOPAMINE; ERYTHROCYTE ENZYME; NORADRENALIN;

ALLELE; ARTICLE; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOIDISM; SCHIZOPHRENIA; SILENT GENE;

EID: 9844257590     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-199723000-00001     Document Type: Article

References (36)

1. Baron M, Gruen R, Levitt M, Hunter C and Asnis L (1984) Erythrocyle catechol O-methyltransferase activity in schizophrenia: analysis of family data. American Journal of Psychiatry, 141, 29-32.
2. BIOMED European Bipolar Collaborative Group (1997) No association between bipolar disorder and alleles at a functional polymorphism in the COMT gene. British Journal of Psychiatry 170, 526-528.
3. Carlson C, Papolos D, Pandita RK, Faedda GL, Veit S, Goldberg R, Shprintzen R, Kucherlapati R and Morrow B (1997) Molecular analysis of velo-cardio facial syndrome patients with psychiatric disorders. American Journal of Human Genetics, 60, 851-859.
4. Cohn CK, Dunner DL and Axelrod J. Reduced catechol-O-methyltransferase activity in red blood cells of women with primary affective disorders (1970) Science, 170, 1323-1324.
5. Coon H, Jensen S, Holik J, Hoff M, Myles-Worsley M, Reimherr F, Wender P, Waldo M, Freedman R, Leppert M and Byerley W (1994) Genomic scan for genes predisposing to schizophrenia. American Journal of Medical Genetics, 54, 59-71.
6. Daniels JK, Williams NM, Williams J, Jones LA, Cardno AG, Murphy KC, Scott L, Spurlock G, Riley B, Scambler P et al. (1996) No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-O-methyltransferase activity. American Journal of Psychiatry, 153, 268-270.
7. Dunham I, Collins J, Wadey R and Scambler P (1992) Possible role for COMT in psychosis associated with velo-cardio-facial syndrome. Lancet, 340, 1361-1362.
8. Fahndrich E, Coper H, Christ W, Helmchen B, Muller-Oerlinghausen B and Pietzkcer A (1980) Erythrocyte COMT activity in patients with affective disorders. Acta Psychiatrica Scandinavica, 61, 427-437.
9. Floderus Y, Ross S and Wetterberg L (1981) Erythrocyte catechol-O-methyltransferase activity in related families with schizophrenia. Clinical Genetics, 19, 379-385.
10. Gill M, McGuffin P, Parfitt E, Mant R, Asherson P, Collier D, Vallada H, Powell J, Shaikh S, Taylor M et al. (1993) A linkage study of schizophrenia with DNA markers from the long arm of chromosome 11. Psychology and Medicine, 23, 27-44.
11. Grossman MH, Emanuel BS and Budarf ML (1992) Chromosomal mapping of the human catecholamine-O-methyltransferase gene to 22q11.1-q11.2. Genomics, 12, 822-825.
12. Guiterrez B, Bertranpetit J, Guillamat R, Valles V, Arranz MJ, Kerwin RW and Fananas L (1996) Association analysis of the catechol-O-methyltransferase gene and bipolar affective disorder. American Journal of Psychiatry, 154, 113-115.
13. Hoda F, Chaudhuri KR, Arranz M, Aitchison KJ, Al-Chalabi A, Kunugi H, Vallada H, Leigh PN and Collier DA (1995) Parkinson's disease and low activity alleles of COMT. Biochemical and Biophysical Research Communications, 228, 780-784.
14. Karayiorgou M, Kasch L, Lasseter VK, Hwang J, Elango R, Benardini DJ, Kimberland M, Babb R, Francomano CA, Wolyniec PS et al. (1994) Report from the Maryland epidemiology schizophrenia linkage study. American Journal of Medical Genetics, 54, 345-353.
15. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, Gos A, Nestadt G, Wolyniec P, Lasseter VK et al. (1995) Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proceedings of the National Academy of Sciences of the United States of America, 92, 7612-7616.
16. Karayiorgou M and Gogos JA (1997) Dissecting the genetic complexity of schizophrenia. Molecular Psychiatry, 2, 211-223.
17. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J and Gogos J (1997) Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive compulsive disorder. Proceedings of the National Academy of Sciences of the United States of America, 94, 4572-4575.
18. Karege F, Bovier JM, Gaillard JM and Tissot R (1987) The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance. Acta Psychiatrica Scandinavica, 76, 303-308.
19. Lachman D, Papolos DF, Saito T, Yu YM, Szumlanski CL and Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6, 243-250.
20. Lachman D, Kelsoe JR, Remick R, Sadovnick AD, Rapaport MH, Lin M, Pazur BA, Roe AMA, Saito T and Papalos DF (1997) Linkage studies suggest a possible locus for bipolar affective disorder near the VCF syndrome region on chromosome 22. American Journal of Medical Genetics, 74, 121-128.
21. Lasseter VK, Pulver AE, Wolyniec PS, Nestadt G, Meyers D, Karayiorgou M, Housman DE, Antonarakis S, Kazazian H, Kasch L et al. (1995) Follow-up report of potential linkage for schizophrenia on chromosome 22q: part 3. American Journal of Medical Genetics, 60, 172-173.
22. Li T, Sham PC, Vallada HP, Xie T, Tang X, Liu X, and Collier DA (1996) Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatric Genetics, 6, 131-133.
23. Li T, Vallada H, Curtis D, Arranz M, Xu K, Cai G, Deng H, Liu J, Murray R, Liu X and Collier DA (1997) Catechol-O-methyltransferase Val158Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics, 7, in press.
24. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I and Taskinen J (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry, 34, 4202-4210.
25. McKenna PJ (1987) Pathology, phenomenology and the dopamine hypothesis of schizophrenia. British Journal of Psychiatry, 151, 288-301.
26. Price-Evans DA (1993) Genetic Factors in Drug Therapy: Clinical and Molecular Pharmacogenetics. Cambridge University Press, Cambridge, UK.
27. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, Morrow B, Karayiorgou M, Antonarakis SE, Housman D and Kucherlapati R (1994) Psychotic illness in patients diagnosed with Velo-Cardio-Facial Syndrome and their relatives. Journal of Nervous and Mental Disease, 182, 476-478.
28. Puzynski S, Bidzinski A, Mrozek S and Zaluska M (1983) Studies on biologic amine metabolizing enzymes (d. b. h., COMT, MAO) and pathogenesis of affective illness. Acta Psychiatrica Scandinavica, 67, 96-100.
29. Scambler P, Kelly D, Lindsay E, Williamson R, Goldberg R, Shprintzen R, Wilson DI, Goodship JA, Cross IE and Burn J (1992) Velo-cardio-facial syndrome associated with chromosome 22 deletions which encompass the DiGeorge syndrome locus. Lancet, 339, 1138-1139.
30. Sham PC and Curtis D (1995) An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Annals of Human Genetics, 59, 323-336.
31. Shprintzen RJ, Goldberg R, Golding-Kushner KJ and Marion R (1992) Late-onset psychosis in the velo-cardio-facial syndrome. American Journal of Medical Genetics, 42, 141-142.
32. Spielman RS, McGinnis RE and Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics, 52, 506-516.
33. Spitzer RL, Endicott J and Robins E (1978) Research Diagnostic Criteria for a Selected Group of Functional Disorders, third edition. New York State Psychiatric Institute, New York.
34. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R and Ulmanen I (1994) Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. European Journal of Biochemistry, 223, 1049-1059.
35. Vallada HP, Gill M, Sham P, Lim LCC, Nanko S, Asherson P, Murray RM, McGuffin P, Owen M and Collier D (1995) Linkage studies on chromosome 22 in familial schizophrenia. American Journal of Medical Genetics, 60, 139-146.
36. Wei J, Ramchand C-N and Hemmings GP (1993) Are gender differences genetically related to catecholamine metabolism in schizophrenia? Journal of Psychiatric Research, 27, 355-360.